Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.40 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.40 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.40 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.40 |
| ▸ | P2RY6 | Q15077 | 8/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.31 |
| ▸ | DUT | P33316 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8099831 | 0.88 | SLC28A1 (0.40) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL2242410 | 0.86 | SLC28A1 (0.44) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL27879786 | 0.84 | SLC28A1 (0.41) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL516166 | 0.84 | SLC28A1 (0.43) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL7866086 | 0.83 | SLC28A1 (0.40) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL10697841 | 0.82 | SLC28A1 (0.41) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL9670017 | 0.82 | SLC28A1 (0.41) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL19149087 | 0.81 | SLC28A1 (0.38) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL95680 | 0.81 | P2RY6 (0.54) | P2RY6 | |
| SCHEMBL15285199 | 0.80 | SLC28A1 (0.40) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025024123-A1 | NOVEL CITICOLINE DERIVATIVES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-30 | — | — | WO | claimed |
| WO-2025024123-A1 | NOVEL CITICOLINE DERIVATIVES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-30 | — | — | WO | disclosed |
| US-10351910-B2 | Gene and protein expression properties of adherent stromal cells cultured in 3D | PLURISTEM LTD (IL) | 2019-07-16 | — | — | US | disclosed |
| US-20180371542-A1 | OPIOID RECEPTOR BLOCKADE IN TREATING ALCOHOL USE DISORDERS | MUSC FOUNDATION FOR RESEARCH DEVELOPMENT (US) | 2018-12-27 | — | — | US | disclosed |
| US-20180369238-A1 | DOPAMINE AGONISTS IN TREATING ALCOHOL USE DISORDERS ASSOCIATED WITH DOPAMINE RECEPTOR ACTIVITY | MUSC FOUNDATION FOR RESEARCH DEVELOPMENT (US) | 2018-12-27 | — | — | US | disclosed |
| EP-3133167-B1 | METHODS RELATING TO FUSIONS OF ALK FOR DIAGNOSING CANCER | INSIGHT GENETICS INC (US) | 2018-09-12 | — | — | EP | disclosed |
| US-20180208993-A1 | HIGHLY SENSITIVE METHODS FOR DETECTING BTK RESISTANCE MUTATIONS IN RNA AND DNA | OHIO STATE INNOVATION FOUNDATION | 2018-07-26 | — | — | US | disclosed |
| EP-1583843-B1 | SINGLE PRIMER WHOLE GENOME AMPLIFICATION | QIAGEN GMBH (DE) | 2018-07-18 | — | — | EP | disclosed |
| EP-2432794-B1 | TRANS-ACTING RNA SWITCHES | THE RES FOUND OF STATE UNIV OF NEW YORK (US) | 2017-08-30 | — | — | EP | disclosed |
| US-9719085-B2 | Trans-acting RNA switches | THE RESEARCH FOUNDATION OF THE UNIVERSITY OF NEW YORK (US) | 2017-08-01 | — | — | US | disclosed |
| WO-2004055197-A2 | THERMODYNAMIC EQUILIBRIUM EXTENSION OF PRIMERS | YALE UNIVERSITY (US) | 2004-07-01 | — | — | WO | disclosed |
| US-20040115643-A1 | Thermodynamic equilibrium extension of primers | YALE UNIVERSITY | 2004-06-17 | — | — | US | disclosed |
| WO-2004027035-A2 | RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES. | YALE UNIVERSITY (US) | 2004-04-01 | — | — | WO | disclosed |
| US-20030228613-A1 | Nucleic acid amplification | QIAGEN GMBH (DE) | 2003-12-11 | — | — | US | disclosed |
| US-6617137-B2 | During replication at least one of the replicated strands is displaced from the genome by strand displacement replication of another replicated strand. | MOLECULAR STAGING INC. | 2003-09-09 | — | — | US | disclosed |
| WO-2003066908-A1 | DETECTION METHOD USING DISSOCIATED ROLLING CIRCLE AMPLIFICATION | MOLECULAR STAGING, INC. (US) | 2003-08-14 | — | — | WO | disclosed |
| US-20030152932-A1 | Detection method using dissociated rolling circle amplification | QIAGEN GMBH (DE) | 2003-08-14 | — | — | US | disclosed |
| US-20030143587-A1 | Nucleic acid amplification | MOLECULAR STAGING, INC. | 2003-07-31 | — | — | US | disclosed |
| US-20030118998-A1 | Nucleic acid amplification | QIAGEN GMBH (DE) | 2003-06-26 | — | — | US | disclosed |
| WO-2003033724-A2 | NUCLEIC ACID AMPLIFICATION | MOLECULAR STAGING, INC. (US) | 2003-04-24 | — | — | WO | disclosed |